© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Effects of glycosylated hemoglobin on vascular responses in vitro
Department of Internal Medicine and the Cardiovascular Center, University of Iowa, Iowa City, IA and the Department of Veterans Affairs, Iowa City, IA, USA
* Corresponding author: 200 ML, Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA. Tel. +1 319 335-7633; Fax +1 319 353-6343; E-mail: coltman@blue.weeg.uiowa.edu
Vascular responses to endothelium-dependent vasodilators are greatly impaired in vivo, while isolated blood vessels from animals with diabetes mellitus demonstrate less consistent degrees of impairment. Glycation of proteins, such as hemoglobin, has been implicated in the vascular abnormalities associated with diabetes. Objective: The purpose of this study was to test the hypothesis that glycosylated hemoglobin is capable of reducing endothelium-dependent vasodilator responses, possibly explaining impaired dilation observed in vivo. Methods: To test this hypothesis, the effect of glycosylated hemoglobin (GH) on vascular responses was studied in several vascular beds, including ventricular microvessels and coronary, mesenteric, femoral, and renal arteries. Coronary arterioles were isolated and mounted between two glass pipettes in a pressurized (30 cmH2O) organ chamber. Isolated artery segments were studied using a standard isometric ring technique. Results: In ventricular microvessels, 10 nM nGH (non-GH) and GH both attenuated the relaxation to Ach. A lower concentration, 1 nM nGH or GH, did not alter dilation to Ach. In coronary, femoral, mesenteric and renal artery segments, endothelium-dependent responses were not altered by the presence of 10 or 100 nM nGH or GH. Conclusion: In coronary microvessels, and coronary, femoral, mesenteric and renal arteries, GH is not responsible for the impaired endothelial function associated with diabetes mellitus.
KEYWORDS Glycosylated hemoglobin; Diabetes; Coronary vasculature; Microcirculation; Acetylcholine; Dog, arteries
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. L. Oltman, L. L. Richou, E. P. Davidson, L. J. Coppey, D. D. Lund, and M. A. Yorek Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1780 - H1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lakhani, W. Yang, A. Dooley, E. El-Mahdi, M. Sundaresan, S. McLellan, R. Bruckdorfer, A. Leonard, A. Seifalian, and P. Hardiman Aortic function is compromised in a rat model of polycystic ovary syndrome Hum. Reprod., March 1, 2006; 21(3): 651 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, C. L. Oltman, T. Lu, H.-C. Lee, K. C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BKCa channels Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2430 - H2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Zink, C. L. Oltman, T. Lu, P. V. G. Katakam, T. L. Kaduce, H.-C. Lee, K. C. Dellsperger, A. A. Spector, P. R. Myers, and N. L. Weintraub 12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H693 - H704. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Oltman, N. L. Kane, D. D. Gutterman, R. S. Bar, and K. C. Dellsperger Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E176 - E181. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Oltman, N. L. Weintraub, M. VanRollins, and K. C. Dellsperger Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids Are Potent Vasodilators in the Canine Coronary Microcirculation Circ. Res., November 2, 1998; 83(9): 932 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF] |
||||




